Product Information

GLIPIZIDE ER 2.5 MG TABLET is a generic product labeled by American Health Packaging, priced at $0.0984 per EA under NDC 60687076821. Its NADAC has been published 138 times since Apr 3, 2024.

FDA first approved this application on May 12, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

GLIPIZIDE ER 2.5 MG TABLET

Glipizide
$0.0984per EA

Strength

2.5 mg/1

NDC

60687076821

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

GLIPIZIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA206928

FDA Approved

5/12/2017

TE Code

AB

On Market Since

2/14/2024

Pharmacological Classes

Sulfonylurea Compounds
Sulfonylurea

Price Statistics

The NADAC for GLIPIZIDE ER 2.5 MG TABLET has been published 138 times since Apr 3, 2024, and over the history we have for it it has declined 21.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0984 per EA
All-time high$0.1254 (Apr 10, 2024)
All-time low$0.0974 (Nov 20, 2024)
52-week high$0.1084
52-week low$0.0982
Median price$0.1086
Average price$0.1091
Largest weekly change-20.0% (Nov 20, 2024)
Weeks tracked138
Tracking sinceApr 3, 2024

Price History

1W

+0.2%

1M

-0.9%

3M

-2.7%

6M

-4.7%

1Y

-9.2%

3Y

N/A

5Y

N/A

All

-21.5%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of GLIPIZIDE ER 2.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for GLIPIZIDE ER 2.5 MG TABLET, manufactured by American Health Packaging, is $0.0984 per EA (NDC 60687076821), effective Nov 18, 2026.

How has the price of GLIPIZIDE ER 2.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for GLIPIZIDE ER 2.5 MG TABLET has declined 21.5%. It has been tracked across 138 weekly CMS publications since Apr 3, 2024.

What are the highest and lowest recorded NADAC prices for GLIPIZIDE ER 2.5 MG TABLET?

Since Apr 3, 2024, the NADAC for GLIPIZIDE ER 2.5 MG TABLET has ranged from a low of $0.0974 (Nov 20, 2024) to a high of $0.1254 (Apr 10, 2024), with a median of $0.1086 per EA.

Are there cheaper alternatives to GLIPIZIDE ER 2.5 MG TABLET?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GLIPIZIDE ER 2.5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures GLIPIZIDE ER 2.5 MG TABLET?

GLIPIZIDE ER 2.5 MG TABLET (NDC 60687076821) is labeled by American Health Packaging, and CMS classifies it as a generic product.